ROBO vs XBI
ROBO Global Robotics and Automation Index ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.95% for ROBO.
- • XBI pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | ROBO | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.95% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.34% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $2.05B | $10.73B |
YTD return | 16.88% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.77 | 1.10 |
P/E ratio | 30.30 | — |
Last price | $82.81 | $164.01 |
Inception | — | — |
Issuer | ROBO Global | State Street |
ROBO top holdings
| TER | Teradyne Inc | 2.07% |
| AMBA | Ambarella Inc | 1.96% |
| OUST | Ouster Inc Ordinary Shares - Class A | 1.93% |
| ROK | Rockwell Automation Inc | 1.84% |
| NOVT | Novanta Inc | 1.73% |
| IPGP | IPG Photonics Corp | 1.73% |
| 6324.T | Harmonic Drive Systems Inc | 1.70% |
| 6954.T | Fanuc Corp | 1.65% |
| ISRG | Intuitive Surgical Inc | 1.64% |
| JBTM | JBT Marel Corp | 1.61% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ROBO
ROBO (ROBO Global Robotics and Automation Index ETF) is Robotics and automation companies worldwide. Managed by ROBO Global, the fund carries $2.0B in assets under management, an expense ratio of 0.95%, a dividend yield of 0.34%. Its largest holding is Teradyne Inc (TER), which represents 2.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 4.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.